CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Net Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹17,765 Cr | ₹14,147 Cr | ₹11,772 Cr | ₹9,798 Cr | ₹8,590 Cr |
What is the latest Net Current Assets ratio of CIPLA ?
Year | Net Current Assets |
---|---|
Mar2025 | ₹17,765 Cr |
Mar2024 | ₹14,147 Cr |
Mar2023 | ₹11,772 Cr |
Mar2022 | ₹9,798 Cr |
Mar2021 | ₹8,590 Cr |
How is Net Current Assets of CIPLA Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹17,765 Cr | 25.58 | |
Mar2024 | ₹14,147 Cr | 20.17 | |
Mar2023 | ₹11,772 Cr | 20.15 | |
Mar2022 | ₹9,798 Cr | 14.06 | |
Mar2021 | ₹8,590 Cr | - |
Compare Net Current Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹126,319.7 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics | |
MANKIND PHARMA | ₹102,043.0 Cr | 0.3% | -5.8% | 13.5% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 5.3% |
6.1% |
-1.3% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses